Playback speed
10 seconds
ASH 2022 Health-Related QOL in Patients With Hemophilia A or B With Inhibitors on Concizumab Prophylaxis: Results From the Phase 3 explorer7 Study
By
ASH 2022 Conference Coverage
FEATURING
Amy Shapiro
By
ASH 2022 Conference Coverage
FEATURING
Amy Shapiro
74 views
December 28, 2022
Login to view comments.
Click here to Login